Nutrition & Lifestyle
Retatrutide
Retatrutide Meal Plan
Published April 3, 2026•Updated August 24, 2026
Retatrutide is an investigational medication in clinical trials. It is not FDA-approved, is not legally compoundable, and is not available through Trimi. Trimi does not offer it and has no plans to. This article is editorial safety coverage for people researching the drug-development pipeline.
This article is general information, not medical or nutritional advice. Individual needs vary with health conditions, medications, and kidney function; consult a licensed clinician or registered dietitian before making significant dietary changes. Compounded medications are prepared per individual prescription by a state-licensed 503A pharmacy and are not themselves FDA-approved as drugs.
Related Reading
Sources & References
- Jastreboff AM et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial. NEJM 2023. pubmed.ncbi.nlm.nih.gov/37366315
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021. pubmed.ncbi.nlm.nih.gov/33567185
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022. pubmed.ncbi.nlm.nih.gov/35658024
- Institute of Medicine. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. National Academies Press, 2005. nap.nationalacademies.org/catalog/10925
- U.S. Food and Drug Administration. Human Drug Compounding. fda.gov/drugs/human-drug-compounding
- ClinicalTrials.gov, U.S. National Library of Medicine. clinicaltrials.gov